MDT

95.97

-0.18%↓

137.66

+1.08%↑

VEEV

219.44

-1.64%↓

HQY

91.05

-0.5%↓

PHR.US

16.26

-3.79%↓

MDT

95.97

-0.18%↓

137.66

+1.08%↑

VEEV

219.44

-1.64%↓

HQY

91.05

-0.5%↓

PHR.US

16.26

-3.79%↓

MDT

95.97

-0.18%↓

137.66

+1.08%↑

VEEV

219.44

-1.64%↓

HQY

91.05

-0.5%↓

PHR.US

16.26

-3.79%↓

MDT

95.97

-0.18%↓

137.66

+1.08%↑

VEEV

219.44

-1.64%↓

HQY

91.05

-0.5%↓

PHR.US

16.26

-3.79%↓

MDT

95.97

-0.18%↓

137.66

+1.08%↑

VEEV

219.44

-1.64%↓

HQY

91.05

-0.5%↓

PHR.US

16.26

-3.79%↓

Home・Akcijų sąrašas・Microbot Medical Inc

Microbot Medical Inc

Uždarymo kaina

2.1 5

Pirkti Parduoti

Apžvalga

Akcijų kainos pasikeitimas

24 val.

Dabar

Min

Max

2.11

Pagrindiniai rodikliai
By Trading Economics
Pajamos	-77K -3.6M
Darbuotojai	20
EBITDA	-79K -3.6M

Rekomendacijos
By TipRanks
Rekomendacijos	Pirkti
12 mėnesių prognozė	+337.5% upside

Dividendai
By Dow Jones
Kitas uždarbis	2026-03-23

Rinkos statistika
By TradingEconomics
Rinkos kapitalizacija	1.3M 142M
Ankstesnė atidarymo kaina	-2.9
Ankstesnė uždarymo kaina	2.1

Techninis įvertinimas

By Trading Central

Pasitikėjimas

Neutral Evidence

2.52 / 2.57 Palaikymas ir pasipriešinimas

Microbot Medical Inc Grafikas

Ankstesni rezultatai nėra patikimas būsimų rezultatų rodiklis.

Susijusios naujienos

2026-01-02 22:45; UTC

Pagrindinės rinkos jėgos

GH Research Shares Up, Plans to Provide Update on New Drug Application

2026-01-02 22:13; UTC

Rinkos pokalbiai

Uždarbis

Tesla Seen As Quiet on Artificial-Intelligence Efforts -- Market Talk

2026-01-02 21:50; UTC

Rinkos pokalbiai

Įsigijimai, susijungimai, perėmimai

Tech, Media & Telecom Roundup: Market Talk

2026-01-02 21:50; UTC

Rinkos pokalbiai

Auto & Transport Roundup: Market Talk

2026-01-02 21:07; UTC

Uždarbis

Tesla Stock Pops and Drops After Fourth-Quarter Deliveries. -- Barrons.com

2026-01-02 20:09; UTC

Rinkos pokalbiai

Oil Futures Slip in First Trading Day of the Year -- Market Talk

2026-01-02 19:48; UTC

Rinkos pokalbiai

U.S. Natural Gas Futures Kick Off 2026 With A Loss -- Market Talk

2026-01-02 18:53; UTC

Rinkos pokalbiai

Global Forex and Fixed Income Roundup: Market Talk

2026-01-02 18:53; UTC

Rinkos pokalbiai

Mexico PMIs Show Manufacturing Weakness in December -- Market Talk

2026-01-02 17:56; UTC

Rinkos pokalbiai

Įsigijimai, susijungimai, perėmimai

Meta's Manus Acquisition May Help Fill AI Monetization Gap -- Market Talk

2026-01-02 17:50; UTC

Rinkos pokalbiai

Apparel Industry Seen With Strength Across Income Levels -- Market Talk

2026-01-02 17:20; UTC

Rinkos pokalbiai

Auto & Transport Roundup: Market Talk

2026-01-02 16:33; UTC

Rinkos pokalbiai

Remittances to Mexico Fell 5.7% in November -- Market Talk

2026-01-02 16:18; UTC

Rinkos pokalbiai

Tesla Dethroned as World's Largest EV Maker -- Market Talk

2026-01-02 15:48; UTC

Uždarbis

Software Has Been Battered by AI. Shopify, Veeva, and 3 More Stocks to Play a Turnaround. -- Barrons.com

2026-01-02 15:17; UTC

Rinkos pokalbiai

Tesla Expected to Make Its Switch to Robotics, AI in 2026 -- Market Talk

2026-01-02 15:01; UTC

Rinkos pokalbiai

Sable Seen Nearing Production Relaunch After Court Ruling -- Market Talk

2026-01-02 15:00; UTC

Uždarbis

The Maker of Biscoff Cookies Bets on a Global Expansion -- WSJ

2026-01-02 14:56; UTC

Rinkos pokalbiai

Tesla's Sales Drop Was Better Than Feared -- Market Talk

2026-01-02 14:20; UTC

Rinkos pokalbiai

Capstone Copper's Mantoverde Strike Could Be Costly -- Market Talk

2026-01-02 14:20; UTC

Rinkos pokalbiai

Global Equities Roundup: Market Talk

2026-01-02 14:13; UTC

Rinkos pokalbiai

Oil Futures Open Year Lower on Oversupply Concerns -- Market Talk

2026-01-02 13:39; UTC

Rinkos pokalbiai

U.S. Natural Gas Futures Open Year Lower -- Market Talk

2026-01-02 13:01; UTC

Rinkos pokalbiai

Įsigijimai, susijungimai, perėmimai

Unicredit Could Buy Delfin's BMPS Stake, Launch Full Takeover, Equita Says -- Market Talk

2026-01-02 12:45; UTC

Rinkos pokalbiai

Emerging-Market Dollar Bonds Record Strong Returns in 2025 -- Market Talk

2026-01-02 11:48; UTC

Rinkos pokalbiai

European Gas Climbs as Cold Weather Bites -- Market Talk

2026-01-02 11:36; UTC

Rinkos pokalbiai

Treasury Yields, Dollar Edge Higher as Near-Term Fed Rate Cut Looks Unlikely -- Market Talk

2026-01-02 11:30; UTC

Rinkos pokalbiai

Copper Rally Continues, Spurred by Supply Shocks -- Market Talk

2026-01-02 11:29; UTC

Rinkos pokalbiai

Dollar Rises After Posting Worst Year Since 2017 -- Market Talk

2026-01-02 11:15; UTC

Rinkos pokalbiai

Global Energy Roundup: Market Talk

Akcijų palyginimas

Kainos pokytis

Microbot Medical Inc Prognozė

Kainos tikslas

By TipRanks

337.5% į viršų

12 mėnesių prognozė

Vidutinis 8.75 USD 337.5%

Aukščiausias 12 USD

Žemiausias 5.5 USD

Remiantis 2 „Wall Street“ analitikais, siūlančiais 12 mėnesių tikslines Microbot Medical Inc kainas – Dist per pastaruosius 3 mėnesius.

Bendras įvertinimas

By TipRanks

Pirkti

2 ratings

Pirkti

Laikyti

Parduoti

Remiantis 2 analitikų, pateikusių Microbot Medical Inc akcijų reitingus – Dist per pastaruosius 3 mėnesius.

Techninis įvertinimas

By Trading Central

2.52 / 2.57Palaikymas ir pasipriešinimas

The bullish and bearish events are balanced.

Recent bullish events outweigh bearish events.

All events are bullish.

Finansinės naujienos

Pardavimo ir administravimo išlaidos

Veiklos sąnaudos

Ikimokestinis pelnas

Pardavimai

Pardavimo savikaina

Bendrasis pelnas iš pardavimo

Skolų palūkanų išlaidos

EBITDA

Veiklos pelnas

Apie bendrovę Microbot Medical Inc

Microbot Medical Inc., a pre-clinical medical device company, engages in the research, design, and development of robotic endoluminal surgery devices targeting the minimally invasive surgery space. The company offers LIBERTY, an endovascular robotic surgical system which allows physicians to conduct a catheter-based procedure from outside the catheterization laboratory, and avoid radiation exposure, physical strain, and the risk of cross contamination for use in cardiovascular, peripheral, and neurovascular spaces. It also provides NovaCross, an intellectual property and technology in the field of intraluminal revascularization devices with anchoring mechanism and integrated microcatheter. The company has a strategic collaboration agreement with Stryker Corporation for technology co-development; and Phase 2 collaboration agreement with Corewell Health for the development of LIBERTY endovascular robotic system. Microbot Medical Inc. was founded in 2010 and is based in Braintree, Massachusetts.